E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients-Reference-Cited by-同舟云学术

E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients

Published:2019-06-23 Issue:11 Volume:32 Page:1574-1586
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Lobo João^ORCID,Petronilho Sara,Newell Amy Hanlon,Coach Julia,Harlow Greg,Cruz Andréia,Lopes Paula,Antunes Luís^ORCID,Bai Isaac,Walker Espen,Henrique Rui^ORCID

Funder

FCT - Agency of the Portuguese Governement for support of scientific and tecnhological research

Ventana Medical Systems partially funded this study through a project grant

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41379-019-0294-9.pdf

Reference45 articles.

1. Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, et al. Outcome of special types of luminal breast cancer. Ann Oncol. 2012;23:1428–36.

2. Prat A, Pineda E, Adamo B, Galvan P, Fernandez A, Gaba L, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26–35.

3. Nicolini A, Ferrari P, Duffy MJ. Prognostic and predictive biomarkers in breast cancer: past, present and future. Semin Cancer Biol. 2017;56–73.

4. Andrews JL, Kim AC, Hens JR. The role and function of cadherins in the mammary gland. Breast Cancer Res. 2012;14:203.

5. Yulis M, Kusters DHM, Nusrat A. Cadherins: cellular adhesive molecules serving as signalling mediators. J Physiol. 2018;596:3883–98.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma;Modern Pathology;2024-10

2. KLHL14 and E-Cadherin Nuclear Co-Expression as Predicting Factor of Nonfunctioning PitNET Invasiveness: Preliminary Study;Journal of Clinical Medicine;2024-07-28

3. Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium;Modern Pathology;2024-07

4. Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment;Seminars in Oncology;2024-06

5. Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition (EMT): Immunohistochemical Characterization of Tumor Budding;International Journal of Gynecological Pathology;2023-01-10